Nonalcoholic fatty liver disease (NAFLD) is a heterogeneous and complex disease that is
imprecisely diagnosed by liver biopsy. NAFLD covers a spectrum that ranges from simple …

Background Hepatocellular (HCC) and extrahepatic cancers have been associated with non-
alcoholic fatty liver disease (NAFLD); however, the extent and nature of these relationships …

The prevalence of hepatocellular carcinoma (HCC) is increasing worldwide, whereas that of
most other cancers is decreasing. Non-alcoholic fatty liver disease (NAFLD), which has …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver
disease worldwide with a reported prevalence ranging 6–33%, depending on the studied …

Risk of cardiovascular disease and loss in life expectancy i... : Hepatology Risk of
cardiovascular disease and loss in life expectancy in NAFLD : Hepatology AASLD Publications …

Liver is the largest solid organ in the body that performs over 100 functions. It removes the
toxins and waste products from the blood stream, maintains healthy blood sugar levels …

Objective Some data suggest a positive association between non-alcoholic fatty liver
disease (NAFLD) and incident major adverse cardiovascular events (MACEs). However …

Background & Aims Hepatocellular carcinoma (HCC) risk stratification in individuals with
dysmetabolism is a major unmet need. Genetic predisposition contributes to non-alcoholic …

Nonalcoholic fatty liver disease (NAFLD) is easily the most common cause of chronic liver
disease in the United States (US) as the hepatic manifestation of the metabolic syndrome …

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) encompasses a wide
spectrum of conditions ranging from simple hepatic steatosis to nonalcoholic steatohepatitis …